Helixmith Co., Ltd (084990.KQ)

KRW 2770.0

(0.0%)

Total Assets Summary of Helixmith Co., Ltd

Helixmith Co., Ltd's latest annual total assets in 2023 was 227.27 Billion KRW , down -10.54% from previous year.
Helixmith Co., Ltd's latest quarterly total assets in 2024 Q2 was 153.87 Billion KRW , down -23.74% from previous quarter.
Helixmith Co., Ltd reported annual total assets of 254.06 Billion KRW in 2022, down -10.07% from previous year.
Helixmith Co., Ltd reported annual total assets of 282.5 Billion KRW in 2021, down -40.92% from previous year.
Helixmith Co., Ltd reported quarterly total assets of 153.87 Billion KRW for 2024 Q2, down -23.74% from previous quarter.
Helixmith Co., Ltd reported quarterly total assets of 250.38 Billion KRW for 2023 Q1, down -1.45% from previous quarter.

Annual Total Assets Chart of Helixmith Co., Ltd (2023 - 2012)

Historical Annual Total Assets of Helixmith Co., Ltd (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	227.27 Billion KRW	-10.54%
2022	254.06 Billion KRW	-10.07%
2021	282.5 Billion KRW	-40.92%
2020	478.13 Billion KRW	28.73%
2019	371.43 Billion KRW	30.68%
2018	284.23 Billion KRW	58.45%
2017	179.38 Billion KRW	0.76%
2016	178.03 Billion KRW	152.14%
2015	70.61 Billion KRW	0.0%
2013	69.62 Billion KRW	2.4%
2012	67.99 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	201.76 Billion KRW	-11.22%
2024 Q2	153.87 Billion KRW	-23.74%
2023 Q1	250.38 Billion KRW	-1.45%
2023 FY	227.27 Billion KRW	-10.54%
2023 Q4	227.27 Billion KRW	-0.09%
2023 Q3	227.47 Billion KRW	-5.25%
2023 Q2	240.06 Billion KRW	-4.12%
2022 Q3	250.86 Billion KRW	-5.06%
2022 Q2	264.22 Billion KRW	-3.09%
2022 Q1	272.65 Billion KRW	-3.49%
2022 FY	254.06 Billion KRW	-10.07%
2022 Q4	254.06 Billion KRW	1.27%
2021 Q3	307.73 Billion KRW	-17.55%
2021 Q1	391.1 Billion KRW	-18.2%
2021 FY	282.5 Billion KRW	-40.92%
2021 Q2	373.22 Billion KRW	-4.57%
2021 Q4	282.5 Billion KRW	-8.2%
2020 Q4	478.13 Billion KRW	44.18%
2020 Q3	331.62 Billion KRW	-10.25%
2020 Q1	383.46 Billion KRW	3.24%
2020 Q2	369.5 Billion KRW	-3.64%
2020 FY	478.13 Billion KRW	28.73%
2019 Q1	300.62 Billion KRW	5.76%
2019 FY	371.43 Billion KRW	30.68%
2019 Q4	371.43 Billion KRW	-14.37%
2019 Q3	433.76 Billion KRW	43.41%
2019 Q2	302.46 Billion KRW	0.61%
2018 Q3	289.66 Billion KRW	64.47%
2018 Q1	177.1 Billion KRW	-1.27%
2018 FY	284.23 Billion KRW	58.45%
2018 Q4	284.23 Billion KRW	-1.88%
2018 Q2	176.12 Billion KRW	-0.55%
2017 Q4	179.38 Billion KRW	0.0%
2017 FY	179.38 Billion KRW	0.76%
2016 FY	178.03 Billion KRW	152.14%
2015 FY	70.61 Billion KRW	0.0%
2014 Q3	68.27 Billion KRW	-0.76%
2014 Q2	68.79 Billion KRW	0.26%
2014 Q1	68.61 Billion KRW	-1.45%
2013 Q3	69.98 Billion KRW	1.37%
2013 Q1	68.17 Billion KRW	0.27%
2013 Q2	69.03 Billion KRW	1.26%
2013 Q4	69.62 Billion KRW	-0.51%
2013 FY	69.62 Billion KRW	2.4%
2012 FY	67.99 Billion KRW	0.0%
2012 Q4	67.99 Billion KRW	0.0%

Peer Total Assets Comparison of Helixmith Co., Ltd

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	69.765%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-130.472%
BINEX Co., Ltd.	257.01 Billion KRW	11.568%
Bioneer Corporation	315.48 Billion KRW	27.959%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-52.096%
MEDIPOST Co., Ltd.	449.39 Billion KRW	49.425%
CrystalGenomics, Inc.	243.11 Billion USD	6.514%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	86.829%
Medy-Tox Inc.	611.62 Billion KRW	62.84%
Peptron, Inc.	52.49 Billion KRW	-332.946%
Amicogen, Inc.	467.09 Billion KRW	51.342%
Genexine, Inc.	376.58 Billion KRW	39.648%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	-13.19%
LegoChem Biosciences, Inc.	189.5 Billion KRW	-19.935%
ALTEOGEN Inc.	256.09 Billion KRW	11.254%
PharmaResearch Co., Ltd.	535.28 Billion KRW	57.54%
SillaJen, Inc.	76.71 Billion KRW	-196.265%
JETEMA, Co., Ltd.	252.14 Billion KRW	9.862%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-121.035%
Genomictree Inc.	132.84 Billion KRW	-71.087%
MedPacto, Inc.	80.47 Billion KRW	-182.424%
D&D Pharmatech	79.2 Billion KRW	-186.956%
EASY BIO,Inc.	172.04 Billion KRW	-32.107%
GI Innovation, Inc.	81.34 Billion KRW	-179.418%